Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol

PURPOSE: In the absence of head-to-head clinical trials comparing the once-daily, long-acting beta2-agonists olodaterol and indacaterol for the treatment of chronic obstructive pulmonary disease (COPD), an indirect treatment comparison by systematic review and synthesis of the available clinical evi...

Full description

Saved in:
Bibliographic Details
Main Authors: Roskell, Neil S, Anzueto, Antonio, Hamilton, Alan, Disse, Bernd, Becker, Karin
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2014
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124050/
https://ncbi.nlm.nih.gov/pubmed/25114521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S59673
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items